A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.
Zheng X, Zhang W, Zhou H, Cao R, Shou Z, Zhang S, Cheng Y, Chen X, Ding C, Li N, Shi S, Zhou Q, Chen Q, Chen G, Chen Z, Zhou P, Hu X, Xue W, Zhang X, Na N, Wang W.
Zheng X, et al. Among authors: cheng y.
Chin Med J (Engl). 2023 Mar 5;136(5):607-609. doi: 10.1097/CM9.0000000000002604.
Chin Med J (Engl). 2023.
PMID: 36921118
Free PMC article.
Clinical Trial.
No abstract available.